clinical trial · NCT04654208
Swedish Ibrance Registries Insights (SIRI)
Malignant Neoplasm of Breastpalbociclib
brief summary
The main objectives of this study are to describe patient characteristics, treatment patterns and clinical outcomes of patients receiving palbociclib in Swedish clinical practice.
started
Dec 15, 2020
primary completion
May 31, 2026
completion
May 31, 2026
last updated
Oct 22, 2026
official title
PALBOCICLIB TREATMENT PATTERNS IN SWEDISH PATIENTS WITH METASTATIC BREAST CANCER - SWEDISH IBRANCE REGISTRIES INSIGHTS (SIRI)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol